Could the agency be on board with approving Moderna's influenza vaccine?
Moderna's stock experienced a significant surge following an unexpected positive view from the FDA. Market observers are speculating that the U.S. regulatory agency could be on the verge of approving Moderna's innovative influenza vaccine. This potential regulatory nod has…
Market Samachar is a news aggregator. This article was originally published by Investor's Business Daily. Tap the button above to read the full story on their site.